Kovai Medical Center & Hospital share news and announcements
NSE: KOVAIBSE: 523323Healthcare ServicesSmall Cap
Last close ₹5,757.50down ₹49.00 (0.84%)BSE ₹5,737.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹5,806.50.
52-week range of BSE trades to 23 Oct 2026
₹5,010.00Low, 30 Mar 2026₹6,725.00High, 27 Oct 2025
- Next results date: the board meets on 11 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,300 Cr728th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 24.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 4.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 20.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.28
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 9,44061.4% delivered
Kovai Medical Center & Hospital share news and announcements
1,043 announcements, routine notices left out, newest first. Page 19 of 21.
May 2011
Apr 2011
25 Apr · Results
Company in consultation with the Statutory Auditors decided to publish the Audited Financial Results for the quarter ended ....15 Apr · Updates
Company in consultation with the Statutory Auditors decided to Publish the Audited Financial Results for the quarter ended 31st March, 2011 before 30th May 2011. Hence, the Company will not consider and publish the Unaudited Financial Results for the quarter ended 31st March, 2011. (Source MSE)15 Apr · Results
Updates6 Apr · Disclosure
Details of acquisition of 1,552 Equity Shares of the Company by Dr. Thavamani Devi Palanisawami, in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. (Source MSE)6 Apr · Business
Disclosure under SEBI Takeover Regulations
Mar 2011
Feb 2011
28 Feb · Disclosure
Details of acquisition of Equity shares of the Company by Dr. Thavamani Devi Palaniswami, in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. Attachments follows (Source MSE)28 Feb · Disclosure
Details of acquisition of Equity shares of the Company by Dr. Thavamani Palaniswami, in terms of SEBI(Prohibition of Insider Trading) Regulations 1992. Attachment follows (Source MSE)28 Feb · Business
Disclosure under SEBI Takeover Regulations28 Feb · Business
Disclosure under Insider Trading Regulation9 Feb · Disclosure
Details of purchase of 680 Equity shares of the Company by Dr. Thavamani Devi Palaniswami, in terms of Regulation 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 2003. (Source MSE)9 Feb · Disclosure
Disclosure under Insider Trading Regulation